Natriuretic peptide-dependent lipolysis in fat cells is a primate specificity

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 283, Issue 1 52-1, 2002, Pages

  Sengenès, Coralie ^a   Zakaroff Girard, Alexia ^a   Moulin, Agnès ^a   Berlan, Michel ^a   Bouloumié, Anne ^a   Lafontan, Max ^a   Galitzky, Jean ^a  

^a INSERM   (France)

Author keywords

Adipose tissue; cGMP; Guanylyl cyclase; Receptor subtypes

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLIC GMP; GUANYLATE CYCLASE; GUANYLYL CYCLASE RECEPTOR A; ISOPRENALINE; MEMBRANE RECEPTOR; NATRIURETIC FACTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ANIMAL CELL; ARTICLE; BLOOD PRESSURE REGULATION; CELL ISOLATION; CELL SPECIFICITY; CONTROLLED STUDY; DOG; FEMALE; HAMSTER; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPOLYSIS; MACACA; MALE; MOUSE; NATRIURESIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RABBIT; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; SPECIES COMPARISON;

EID: 0036333687     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00453.2001     Document Type: Article

References (55)

1. The characterization of ovine genes for atrial, brain and c-type natriuretic peptides
2. Atrial natriuretic peptide-C receptor and membrane signaling in hypertension
3. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system
4. Differences in lipolysis between human subcutaneous and omental adipose tissues
5. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis
6. β-adrenergic control of lipolysis in primate white fat cells: A comparative study with nonprimate mammals
7. Control of lipolysis in intra-abdominal fat cells of nonhuman primates: Comparison with humans
8. Radiometric assays for glycerol, glucose, and glycogen
9. Mechanisms regulating adipocyte lipolysis
10. Lipolytic effects of β1-, β2-, and β3-adrenergic agonists in white adipose tissue of mammals
11. Selective activation of β3-adrenoceptors by octopamine: Comparative studies in mammalian fat cells
12. C-type natriuretic peptide: The endothelial component of the natriuretic peptide system
13. cGMP-inhibited phosphodiesterases (PDE III gene family)
14. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3)
15. Localisation of atrial natriuretic factor receptors in the mesenteric arterial bed
16. Plasma atrial natriuretic peptide and natriuretic peptide receptor gene expression in adipose tissue of normotensive and hypertensive obese patients
17. Assay of guanylyl cyclase catalytic activity
18. The lipid-mobilizing effect of atrial natriuretic peptide is unrelated to sympathetic nervous system activation or obesity in young men
19. Receptors for atrial natriuretic peptide on isolated rat adipocytes
20. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet
21. Immunocytochemical localization, binding, and effects of atrial natriuretic peptide in rat adipocytes
22. Identification and quantification of human kidney atrial natriuretic peptide receptors
23. Altered expression of C/EBP family members results in decreased adipogenesis with aging
24. Cloning properties and tissue distribution of natriuretic peptide receptor-A of euryhaline eel, Anguilla japonica
25. C-type natriuretic peptide
26. Fat cell adrenergic receptors and the control of white and brown fat cell function
27. Fat cell α-2 adrenoceptors: The regulation of fat cell function and lipolysis
28. Recent developments on lipolysis regulation in humans and discovery of a new lipolytic pathway
29. Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species
30. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia
31. Physiologic basis for the control of body fat distribution in humans
32. Physiological studies of the natriuretic peptide family
33. Catecholamine-induced lipolysis in adipose tissue of the elderly
34. Receptors of natriuretic peptides: Structure, function, and regulation
35. Mechanisms for activation of the rat adipocyte particulate cyclic GMP inhibited cyclic AMP phosphodiesterase and its importance in the antilipolytic action of insulin
36. Type III cyclic nucleotide phosphodiesterase and insulin action
37. Changes in catecholamine-induced lipolysis in isolated human fat cells during the first year of life
38. Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue
39. Gender differences in lipid and glucose kinetics during short-term fasting
40. Studies on hormonal regulation of lipolysis and lipogenesis in fat cells of various mammalian species
41. Cytoplasmic domain of natriuretic peptide receptor-C (NPR-C) constitutes Gi-activator sequences that inhibit adenylyl cyclase activity
42. Guanylyl cyclase-linked natriuretic peptide receptors: Structure and regulation
43. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis
44. Expression of natriuretic peptide receptors in human adipose and other tissues
45. Fasting inhibits natriuretic peptide clearance receptor expression in rat adipose tissue
46. Identification of C-type natriuretic peptide in heart of spiny dogfish shark
47. The guanylyl cyclase family of natriuretic peptide receptors
48. Natriuretic peptides: A new lipolytic pathway in human adipocytes
49. Natriuretic peptide signaling: Molecular and cellular pathways to growth regulation
50. Natriuretic peptides: Physiology, therapeutic potential, and risk stratification in ischemic heart disease
51. Enhanced expression and release of C-type natriuretic peptide in freshwater eels
52. Regulation of natriuretic peptide secretion by the heart
53. Specific potentiation by cyclic AMP of natriuretic peptide-mediated cyclic GMP production in adipose tissue
54. Comparison of the in vitro lipolytic response of human and hamster adipocytes
55. Determinants of leptin gene expression in fat depots of lean mice